Overview
- 5 public-safe observations are available for this inspection.
- 4 structured CFR citations are represented.
- 1 investigator is tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
1 Jun 2026
ISO 13485:2016 Clause 4.1.5
Inadequate monitoring and control over outsourced processes
Cited by Linda Galindo
1 Jun 2026
ISO 13485:2016 Clause 7.1
Planning of product realization not consistent with other QMS processes
Cited by Linda Galindo
1 Jun 2026
ISO 13485:2016 Clause 7.1
Records of risk management activities in product realization not maintained
Cited by Linda Galindo
1 Jun 2026
ISO 13485:2016 Clause 8.2.1
Feedback process procedures not documented
Cited by Linda Galindo
1 Jun 2026
ISO 13485:2016 Clause 8.5.2
Corrective action procedures not documented
Cited by Linda Galindo
Inspected site
BIBioplate IncPlacentia, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| ISO 13485:2016 Clause 7.1 | Cited across public-safe Form 483 observations | 2x |
| ISO 13485:2016 Clause 4.1.5 | Cited across public-safe Form 483 observations | 1x |
| ISO 13485:2016 Clause 8.2.1 | Cited across public-safe Form 483 observations | 1x |
| ISO 13485:2016 Clause 8.5.2 | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 5 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere